A phase I study of VT-1598 for the treatment of mycoses

Next Previous
Trial Profile

A phase I study of VT-1598 for the treatment of mycoses

Planning
Phase of Trial: Phase I

Latest Information Update: 21 May 2015

At a glance

  • Drugs VT 1598 (Primary)
  • Indications Mycoses
  • Focus Adverse reactions

    • Most Recent Events

    • 21 May 2015 New trial record
    • 20 May 2015 Viamet Pharmaceuticals plans to initiate this study in the second-half of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top